Senthilkumar, Palaniappan and Dinakaran, Murugesan and Banerjee, Debjani and Devakaram, Ruth Vandana and Yogeeswari, Perumal and China, Arnab and Nagaraja, Valakunja and Sriram, Dharmarajan (2008) Synthesis and antimycobacterial evaluation of newer 1-cyclopropyl-1,4-dihydro-6-fluoro-7-(substituted secondary amino)-8-methoxy-5-(sub)-4-oxoquinoline-3-carboxylic acids. In: Bioorganic & Medicinal Chemistry, 16 (5). pp. 2558-2569.
PDF
sdarticle.pdf Restricted to Registered users only Download (258kB) | Request a copy |
Abstract
Thirty-four newer 1-cyclopropyl-1,4-dihydro-6-fluoro-7-(substituted secondary amino)-8-methoxy-5-(sub)-4-oxoquinoline-3-carboxylic acids were synthesized from 1,2,3,4-tetrafluoro benzene and evaluated for in vitro and in vivo antimycobacterial activities against Mycobacterium tuberculosis H37Rv (MTB), multi-drug resistant M. tuberculosis (MDR-TB) and Mycobacterium smegmatis $(MC^2)$ and also tested for the ability to inhibit the supercoiling activity of DNA gyrase. Among the synthesized compounds, 7-(1-(4-methoxybenzyl)-3,4,5,6,7,8-hexahydroisoquinolin-2(1H)- l)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-5-nitro-4-oxoquinoline-3-carboxylic acid (13n) was found to be the most active compound in vitro with MIC of 0.16 and 0.33 \mu M against MTB and MDR-TB, respectively. In the in vivo animal model 13n decreased the bacterial load in lung and spleen tissues with 2.54 and 2.92 - log10 protections, respectively, at the dose of 50 mg/kg body weight. Compound 13n also inhibited the supercoiling activity of mycobacterial DNA gyrase with $IC_{50}$ of 30.0 \mu g/ml.
Item Type: | Journal Article |
---|---|
Publication: | Bioorganic & Medicinal Chemistry |
Publisher: | Elsevier |
Additional Information: | Copyright of this article belongs to Elsevier. |
Department/Centre: | Division of Biological Sciences > Microbiology & Cell Biology |
Date Deposited: | 09 May 2008 |
Last Modified: | 19 Sep 2010 04:44 |
URI: | http://eprints.iisc.ac.in/id/eprint/13923 |
Actions (login required)
View Item |